Loading [MathJax]/jax/output/SVG/jax.js
Research article

Diagnostic value of Endothelin 1 as a marker for diagnosis of pulmonary parenchyma involvement in patients with systemic sclerosis

  • Received: 07 September 2020 Accepted: 07 September 2020 Published: 25 September 2020
  • Background Systemic sclerosis (SSc) is a connective tissue disease and one of the manifestations associated with this disease is pulmonary involvement. Studies showed that endothelin 1 (ET-1) plays a role in pulmonary dysfunction due to SSc. The aim of this study was to determine the level of ET-1 in SSc patients and to evaluate its association with the early stages of pulmonary fibrosis.
    Methods In this cross-sectional study, 48 patients with SSc were enrolled in the study. The stiffness of the skin was evaluated based on the modified Rodnan skin score. CT records, lung function tests and echocardiography were done. The samples were divided into two groups of patients with and without pulmonary parenchymal involvement. Blood sample was taken to measure the serum levels of ET-1 by ELISA method. ANOVA and Tukey HSD tests were used for statistical analysis.
    Results According to pulmonary CT scan, 68.2% of patients had pulmonary involvement. There was no significant difference in the presence of honeycomb lesions and fibrosis in lung CT scan of the patients in case of gender (P = 0.819 and P = 0.356, respectively). There was no statistical difference between the results of spirometry in patients with anti-Scl-70 and anti-centromere test. The mean serum level of ET-1 in the studied population was 0.55 ± 0.232 pg/mL, in the men was 0.47 ± 0.14 pg/mL and in the women was 0.55 ± 0.24 pg/mL. There was no significant difference between the two groups in the case of gender and type of the disease (P = 0.475 and P = 0.150, respectively). The ROC diagram of serum level of ET1 in patients based on the type of the disease shows that the serum level of ET-1 of 55% has 50% sensitivity and 52.2% specificity.
    Conclusion Serum level of ET-1 could not be used for screening of pulmonary involvement in SSc because its sensitivity and specificity is related to pulmonary fibrosis, honeycomb lesions and disease form. Anti Scl-70 with low levels, DLCO, FVC, FEV1, TLC can be used to assess the possibility of pulmonary involvement and response to treatment.

    Citation: Masoud Nazemiyeh, Mehrzad Hajalilou, Mohsen Rajabnia, Akbar Sharifi, Sabah Hasani. Diagnostic value of Endothelin 1 as a marker for diagnosis of pulmonary parenchyma involvement in patients with systemic sclerosis[J]. AIMS Medical Science, 2020, 7(3): 234-242. doi: 10.3934/medsci.2020014

    Related Papers:

    [1] Baiyu Liu, Wenlong Yang . Asymptotic symmetry of solutions for reaction-diffusion equations via elliptic geometry. Communications in Analysis and Mechanics, 2025, 17(2): 341-364. doi: 10.3934/cam.2025014
    [2] He Wang, Yu Liu . Laguerre BV spaces, Laguerre perimeter and their applications. Communications in Analysis and Mechanics, 2023, 15(2): 189-213. doi: 10.3934/cam.2023011
    [3] Jizheng Huang, Shuangshuang Ying . Hardy-Sobolev spaces of higher order associated to Hermite operator. Communications in Analysis and Mechanics, 2024, 16(4): 858-871. doi: 10.3934/cam.2024037
    [4] Zhiyong Wang, Kai Zhao, Pengtao Li, Yu Liu . Boundedness of square functions related with fractional Schrödinger semigroups on stratified Lie groups. Communications in Analysis and Mechanics, 2023, 15(3): 410-435. doi: 10.3934/cam.2023020
    [5] Heng Yang, Jiang Zhou . Some estimates of multilinear operators on tent spaces. Communications in Analysis and Mechanics, 2024, 16(4): 700-716. doi: 10.3934/cam.2024031
    [6] Yang Liu, Xiao Long, Li Zhang . Long-time dynamics for a coupled system modeling the oscillations of suspension bridges. Communications in Analysis and Mechanics, 2025, 17(1): 15-40. doi: 10.3934/cam.2025002
    [7] Cheng Yang . On the Hamiltonian and geometric structure of Langmuir circulation. Communications in Analysis and Mechanics, 2023, 15(2): 58-69. doi: 10.3934/cam.2023004
    [8] Andrea Brugnoli, Ghislain Haine, Denis Matignon . Stokes-Dirac structures for distributed parameter port-Hamiltonian systems: An analytical viewpoint. Communications in Analysis and Mechanics, 2023, 15(3): 362-387. doi: 10.3934/cam.2023018
    [9] Ming Liu, Binhua Feng . Grand weighted variable Herz-Morrey spaces estimate for some operators. Communications in Analysis and Mechanics, 2025, 17(1): 290-316. doi: 10.3934/cam.2025012
    [10] Siegfried Carl . Quasilinear parabolic variational-hemivariational inequalities in RN×(0,τ) under bilateral constraints. Communications in Analysis and Mechanics, 2025, 17(1): 41-60. doi: 10.3934/cam.2025003
  • Background Systemic sclerosis (SSc) is a connective tissue disease and one of the manifestations associated with this disease is pulmonary involvement. Studies showed that endothelin 1 (ET-1) plays a role in pulmonary dysfunction due to SSc. The aim of this study was to determine the level of ET-1 in SSc patients and to evaluate its association with the early stages of pulmonary fibrosis.
    Methods In this cross-sectional study, 48 patients with SSc were enrolled in the study. The stiffness of the skin was evaluated based on the modified Rodnan skin score. CT records, lung function tests and echocardiography were done. The samples were divided into two groups of patients with and without pulmonary parenchymal involvement. Blood sample was taken to measure the serum levels of ET-1 by ELISA method. ANOVA and Tukey HSD tests were used for statistical analysis.
    Results According to pulmonary CT scan, 68.2% of patients had pulmonary involvement. There was no significant difference in the presence of honeycomb lesions and fibrosis in lung CT scan of the patients in case of gender (P = 0.819 and P = 0.356, respectively). There was no statistical difference between the results of spirometry in patients with anti-Scl-70 and anti-centromere test. The mean serum level of ET-1 in the studied population was 0.55 ± 0.232 pg/mL, in the men was 0.47 ± 0.14 pg/mL and in the women was 0.55 ± 0.24 pg/mL. There was no significant difference between the two groups in the case of gender and type of the disease (P = 0.475 and P = 0.150, respectively). The ROC diagram of serum level of ET1 in patients based on the type of the disease shows that the serum level of ET-1 of 55% has 50% sensitivity and 52.2% specificity.
    Conclusion Serum level of ET-1 could not be used for screening of pulmonary involvement in SSc because its sensitivity and specificity is related to pulmonary fibrosis, honeycomb lesions and disease form. Anti Scl-70 with low levels, DLCO, FVC, FEV1, TLC can be used to assess the possibility of pulmonary involvement and response to treatment.


    The theory of the basic and the fractional quantum calculus, that is, the basic (or q-) calculus and the fractional basic (or q-) calculus, play important roles in many diverse areas of the mathematical, physical and engineering sciences (see, for example, [10,15,33,45]). Our main objective in this paper is to introduce and study some subclasses of the class of the normalized p-valently analytic functions in the open unit disk:

    U={z:zCand|z|<1}

    by applying the q-derivative operator in conjunction with the principle of subordination between analytic functions (see, for details, [8,30]).

    We begin by denoting by A(p) the class of functions f(z) of the form:

    f(z)=zp+n=p+1anzn   (pN:={1,2,3,}), (1.1)

    which are analytic and p-valent in the open unit disk U. In particular, we write A(1)=:A.

    A function f(z)A(p) is said to be in the class Sp(α) of p-valently starlike functions of order α in U if and only if

    (zf(z)f(z))>α   (0α<p;zU). (1.2)

    Moreover, a function f(z)A(p) is said to be in the class Cp(α) of p-valently convex functions of order α in U if and only if

    (1+zf(z)f(z))>α   (0α<p;zU). (1.3)

    The p-valent function classes Sp(α) and Cp(α) were studied by Owa [32], Aouf [2,3] and Aouf et al. [4,5]. From (1.2) and (1.3), it follows that

    f(z)Cp(α)zf(z)pSp(α). (1.4)

    Let P denote the Carathéodory class of functions p(z), analytic in U, which are normalized by

    p(z)=1+n=1cnzn, (1.5)

    such that (p(z))>0.

    Recently, Kanas and Wiśniowska [18,19] (see also [17,31]) introduced the conic domain Ωk(k0), which we recall here as follows:

    Ωk={u+iv:u>k(u1)2+v2}

    or, equivalently,

    Ωk={w:wCand(w)>k|w1|}.

    By using the conic domain Ωk, Kanas and Wiśniowska [18,19] also introduced and studied the class k-UCV of k-uniformly convex functions in U as well as the corresponding class k-ST of k-starlike functions in U. For fixed k, Ωk represents the conic region bounded successively by the imaginary axis when k=0. For k=1, the domain Ωk represents a parabola. For 1<k<, the domain Ωk represents the right branch of a hyperbola. And, for k>1, the domain Ωk represents an ellipse. For these conic regions, the following function plays the role of the extremal function:

    pk(z)={1+z1z(k=0)1+2π2[log(1+z1z)]2(k=1)1+11k2cos(2iπ(arccosk)log(1+z1z))(0<k<1)1+1k21sin(π2K(κ)u(z)κ0dt1t21κ2t2)+k2k21(1<k<) (1.6)

    with

    u(z)=zκ1κz(0<κ<1;zU),

    where κ is so chosen that

    k=cosh(πK(κ)4K(κ)).

    Here K(κ) is Legendre's complete elliptic integral of the first kind and

    K(κ)=K(1κ2),

    that is, K(κ) is the complementary integral of K(κ) (see, for example, [48,p. 326,Eq 9.4 (209)]).

    We now recall the definitions and concept details of the basic (or q-) calculus, which are used in this paper (see, for details, [13,14,45]; see also [1,6,7,11,34,38,39,42,54,59]). Throughout the paper, unless otherwise mentioned, we suppose that 0<q<1 and

    N={1,2,3}=N0{0}         (N0:={0,1,2,}).

    Definition 1. The q-number [λ]q is defined by

    [λ]q={1qλ1q(λC)n1k=0qk=1+q+q2+qn1(λ=nN), (1.7)

    so that

    limq1[λ]q=1qλ1q=λ.

    .

    Definition 2. For functions given by (1.1), the q-derivative (or the q-difference) operator Dq of a function f is defined by

    Dqf(z)={f(z)f(qz)(1q)z(z0)f(0)(z=0), (1.8)

    provided that f(0) exists.

    We note from Definition 2 that

    limq1Dqf(z)=limq1f(z)f(qz)(1q)z=f(z)

    for a function f which is differentiable in a given subset of C. It is readily deduced from (1.1) and (1.8) that

    Dqf(z)=[p]qzp1+n=p+1[n]qanzn1. (1.9)

    We remark in passing that, in the above-cited recently-published survey-cum-expository review article, the so-called (p,q)-calculus was exposed to be a rather trivial and inconsequential variation of the classical q-calculus, the additional parameter p being redundant or superfluous (see, for details, [42,p. 340]).

    Making use of the q-derivative operator Dq given by (1.6), we introduce the subclass Sq,p(α) of p-valently q-starlike functions of order α in U and the subclass Cq,p(α) of p-valently q-convex functions of order α in U as follows (see [54]):

    f(z)Sq,p(α)(1[p]qzDqf(z)f(z))>α (1.10)
    (0<q<1;0α<1;zU)

    and

    f(z)Cq,p(α)(1[p]qDp,q(zDqf(z))Dqf(z))>α (1.11)
    (0<q<1;0α<1;zU),

    respectively. From (1.10) and (1.11), it follows that

    f(z)Cq,p(α)zDqf(z)[p]qSq,p(α). (1.12)

    For the simpler classes Sq,p and Cq,p of p-valently q-starlike functions in U and p-valently q-convex functions in U, respectively, we have write

    Sq,p(0)=:Sq,pandCq,p(0)=:Cq,p.

    Obviously, in the limit when q1, the function classes Sq,p(α) and Cq,p(α) reduce to the familiar function classes Sp(α) and Cp(α), respectively.

    Definition 3. A function fA(p) is said to belong to the class Sq,p of p-valently q-starlike functions in U if

    |zDqf(z)[p]qf(z)11q|11q(zU). (1.13)

    In the limit when q1, the closed disk

    |w11q|11q(0<q<1)

    becomes the right-half plane and the class Sq,p of p-valently q-starlike functions in U reduces to the familiar class Sp of p-valently starlike functions with respect to the origin (z=0). Equivalently, by using the principle of subordination between analytic functions, we can rewrite the condition (1.13) as follows (see [58]):

    zDqf(z)[p]qf(z)ˆp(z)   (ˆp(z)=1+z1qz). (1.14)

    We note that Sq,1=Sq (see [12,41]).

    Definition 4. (see [50]) A function p(z) given by (1.5) is said to be in the class k-Pq if and only if

    p(z)2pk(z)(1+q)+(1q)pk(z),

    where pk(z) is given by (1.6).

    Geometrically, the function pk-Pq takes on all values from the domain Ωk,q (k0) which is defined as follows:

    Ωk,q={w:((1+q)w(q1)w+2)>k|(1+q)w(q1)w+21|}. (1.15)

    The domain Ωk,q represents a generalized conic region which was introduced and studied earlier by Srivastava et al. (see, for example, [43,50]). It reduces, in the limit when q1, to the conic domain Ωk studied by Kanas and Wiśniowska [18]. We note the following simpler cases.

    (1) k-PqP(2k2k+1+q), where P(2k2k+1+q) is the familiar class of functions with real part greater than 2k2k+1+q;

    (2) limq1{k-Pq}=P(pk(z)), where P(pk(z)) is the known class introduced by Kanas and Wiśniowska [18];

    (3) limq1{0-Pq}=P, where P is Carathéodory class of analytic functions with positive real part.

    Definition 5. A function fA(p) is said to be in the class k-STq,p if and only if

    ((1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+2)>k|(1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21|(zU) (1.16)

    or, equivalently,

    zDqf(z)[p]qf(z)k-Pq. (1.17)

    The folowing special cases are worth mentioning here.

    (1) k-STq,1=k-STq, where k-STq is the function class introduced and studied by Srivastava et al. [50] and Zhang et al. [60] with γ=1;

    (2) 0-STq,p=Sq,p;

    (3) limq1{k-STq,p}=k-STp, where k-STp is the class of p-valently uniformly starlike functions;

    (4) limq1{0-STq,p}=Sp, where Sp is the class of p-valently starlike functions;

    (5) 0-STq,1=Sq, where Sq (see [12,41]);

    (6) limq1{k-STq,1}=k-ST, where k-ST is a function class introduced and studied by Kanas and Wiśniowska [19];

    (7) limq1{0-STq,1}=S, where S is the familiar class of starlike functions in U.

    Definition 6. By using the idea of Alexander's theorem [9], the class k-UCVq,p can be defined in the following way:

    f(z)k-UCVq,pzDqf(z)[p]qk-STq,p. (1.18)

    In this paper, we investigate a number of useful properties including coefficient estimates and the Fekete-Szegö inequalities for the function classes k-STq,p and k-UCVq,p, which are introduced above. Various corollaries and consequences of most of our results are connected with earlier works related to the field of investigation here.

    In order to establish our main results, we need the following lemmas.

    Lemma 1. (see [16]) Let 0k< be fixed and let pk be defined by (1.6). If

    pk(z)=1+Q1z+Q2z2+,

    then

    Q1={2A21k2(0k<1)8π2(k=1)π24t(k21)[K(t)]2(1+t)(1<k<) (2.1)

    and

    Q2={A2+23Q1(0k<1)23Q1(k=1)4[K(t)]2(t2+6t+1)π224t[K(t)]2(1+t)Q1(1<k<), (2.2)

    where

    A=2arccoskπ,

    and t(0,1) is so chosen that

    k=cosh(πK(t)K(t)),

    K(t) being Legendre's complete elliptic integral of the first kind.

    Lemma 2. Let 0k< be fixed and suppose that

    pk,q(z)=2pk(z)(1+q)+(1q)pk(z), (2.3)

    where pk(z) be defined by (1.6). Then

    pk,q(z)=1+12(1+q)Q1z+12(1+q)[Q212(1q)Q21]z2+ , (2.4)

    where Q1 and Q2 are given by (2.1) and (2.2), respectively.

    Proof. By using (1.6) in (2.3), we can easily derive (2.4).

    Lemma 3. (see [26]) Let the function h given by

    h(z)=1+n=1cnznP

    be analytic in U and satisfy (h(z))>0 for z in U. Then the following sharp estimate holds true:

    |c2vc21|2max{1,|2v1|}(vC).

    The result is sharp for the functions given by

    g(z)=1+z21z2org(z)=1+z1z. (2.5)

    Lemma 4. (see [26]) If the function h is given by

    h(z)=1+n=1cnznP,

    then

    |c2νc21|{4ν+2(ν0)2(0ν1)4ν2(ν1). (2.6)

    When ν>1, the equality holds true if and only if

    h(z)=1+z1z

    or one of its rotations. If 0<ν<1, then the equality holds true if and only if

    h(z)=1+z21z2

    or one of its rotations. If ν=0, the equality holds true if and only if

    h(z)=(1+λ2)(1+z1z)+(1λ2)(1z1+z)(0λ1)

    or one of its rotations. If ν=1, the equality holds true if and only if the function h is the reciprocal of one of the functions such that equality holds true in the case when ν=0.

    The above upper bound is sharp and it can be improved as follows when 0<ν<1:

    |c2νc21|+ν|c1|22(0ν12)

    and

    |c2νc21|+(1ν)|c1|22(12ν1).

    We assume throughout our discussion that, unless otherwise stated, 0k<, 0<q<1, pN, Q1 is given by (2.1), Q2 is given by (2.2) and zU.

    Theorem 1. If a function fA(p) is of the form (1.1) and satisfies the following condition:

    n=p+1{2(k+1)([n]q[p]q)+qn+2[p]q1}|an|<(1+q)[p]q, (3.1)

    then the function fk-STq,p.

    Proof. Suppose that the inequality (3.1) holds true. Then it suffices to show that

    k|(1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21|((1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21)<1.

    In fact, we have

    k|(1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21|((1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21)(k+1)|(1+q)zDqf(z)[p]qf(z)(q1)zDqf(z)[p]qf(z)+21|=2(k+1)|zDqf(z)[p]qf(z)(q1)zDqf(z)+2[p]qf(z)|=2(k+1)|n=p+1([n]q[p]q)anznp(1+q)[p]q+n=p+1((q1)[n]q+2[p]q)anznp|2(k+1)n=p+1([n]q[p]q)|an|(1+q)[p]qn=p+1(qn+2[p]q1)|an|.

    The last expression is bounded by 1 if (3.1) holds true. This completes the proof of Theorem 1.

    Corollary 1. If f(z)k-STq,p, then

    |an|(1+q)[p]q{2(k+1)([n]q[p]q)+qn+2[p]q1}(np+1).

    The result is sharp for the function f(z) given by

    f(z)=zp+(1+q)[p]q{2(k+1)([n]q[p]q)+qn+2[p]q1}zn(np+1).

    Remark 1. Putting p=1 Theorem 1, we obtain the following result which corrects a result of Srivastava et al. [50,Theorem 3.1].

    Corollary 2. (see Srivastava et al. [50,Theorem 3.1]) If a function fA is of the form (1.1) (with p=1) and satisfies the following condition:

    n=2{2(k+1)([n]q1)+qn+1}|an|<(1+q)

    then the function fk-STq.

    Letting q1 in Theorem 1, we obtain the following known result [29,Theorem 1] with

    α1=β1=p,αi=1(i=2,,s+1)andβj=1(j=2,,s).

    Corollary 3. If a function fA(p) is of the form (1.1) and satisfies the following condition:

    n=p+1{(k+1)(np)+p}|an|<p,

    then the function fk-STp.

    Remark 2. Putting p=1 in Corollary 3, we obtain the result obtained by Kanas and Wiśniowska [19,Theorem 2.3].

    By using Theorem 1 and (1.18), we obtain the following result.

    Theorem 2. If a function fA(p) is of the form (1.1) and satisfies the following condition:

    n=p+1([n]q[p]q){2(k+1)([n]q[p]q)+qn+2[p]q1}|an|<(1+q)[p]q,

    then the function fk-UCVq,p.

    Remark 3. Putting p=1 Theorem 1, we obtain the following result which corrects the result of Srivastava et al. [50,Theorem 3.3].

    Corollary 4. (see Srivastava et al. [50,Theorem 3.3]) If a function fA is of the form (1.1) (with p=1) and satisfies the following condition:

    n=2[n]q{2(k+1)([n]q1)+qn+1}|an|<(1+q),

    then the function fk-UCVq.

    Letting q1 in Theorem 2, we obtain the following corollary (see [29,Theorem 1]) with

    α1=p+1,β1=p,α=1(=2,,s+1)andβj=1(j=2,,s).

    Corollary 5. If a function fA(p) is of the form (1.1) and satisfies the following condition:

    n=p+1(np){(k+1)(np)+p}|an|<p,

    then the function fk-UCVp.

    Remark 4. Putting p=1 in Corollary 5, we obtain the following corollary which corrects the result of Kanas and Wiśniowska [18,Theorem 3.3].

    Corollary 6. If a function fA is of the form (1.1) (with p=1) and satisfies the following condition:

    n=2n{n(k+1)k}|an|<1,

    then the function fk-UCV.

    Theorem 3. If fk-STq,p, then

    |ap+1|(1+q)[p]qQ12qp[1]q (3.2)

    and, for all n=3,4,5,,

    |an+p1|(1+q)[p]qQ12qp[n1]qn2j=1(1+(1+q)[p]qQ12qp[j]q). (3.3)

    Proof. Suppose that

    zDqf(z)[p]qf(z)=p(z), (3.4)

    where

    p(z)=1+n=1cnznk-Pq.

    Eq (3.4) can be written as follows:

    zDqf(z)=[p]qf(z)p(z),

    which implies that

    n=p+1([n]q[p]q)anzn=[p]q(zp+n=p+1anzn)(n=1cnzn). (3.5)

    Comparing the coefficients of zn+p1 on both sides of (3.5), we obtain

    ([n+p1]q[p]q)an+p1=[p]q{cn1+ap+1cn2++an+p2c1}.

    By taking the moduli on both sides and then applying the following coefficient estimates (see [50]):

    |cn|12(1+q)Q1(nN),

    we find that

    |an+p1|(1+q)[p]qQ12qp[n1]q{1+|ap+1|++|an+p2|}. (3.6)

    We now apply the principle of mathematical induction on (3.6). Indeed, for n=2, we have

    |ap+1|(1+q)[p]qQ12qp[1]q, (3.7)

    which shows that the result is true for n=2. Next, for n=3 in (3.7), we get

    |ap+2|(1+q)[p]qQ12qp[2]q{1+|ap+1|}.

    By using (3.7), we obtain

    |ap+2|(1+q)[p]qQ12qp[2]q(1+(1+q)[p]qQ12qp[1]q),

    which is true for n=3. Let us assume that (3.3) is true for n=t(tN), that is,

    |at+p1|(1+q)[p]qQ12qp[t1]qt2j=1(1+(1+q)[p]qQ12qp[j]q).

    Let us consider

    |at+p|(1+q)[p]qQ12qp[t]q{1+|ap+1|+|ap+2|++|at+p1|}(1+q)[p]qQ12qp[t]q{1+(1+q)[p]qQ12qp[1]q+(1+q)[p]qQ12qp[2]q(1+(1+q)[p]qQ12qp[1]q)++(1+q)[p]qQ12qp[t1]qt2j=1(1+(1+q)[p]qQ12qp[j]q)}=(1+q)[p]qQ12qp[t]q{(1+(1+q)[p]qQ12qp[1]q)(1+(1+q)[p]qQ12qp[2]q)(1+(1+q)[p]qQ12qp[t1]q)}=(1+q)[p]qQ12qp[t]qt1j=1(1+(1+q)[p]qQ12qp[j]q)

    Therefore, the result is true for n=t+1. Consequently, by the principle of mathematical induction, we have proved that the result holds true for all n(nN{1}). This completes the proof of Theorem 3.

    Similarly, we can prove the following result.

    Theorem 4. If fk-UCVq,p and is of form (1.1), then

    |ap+1|(1+q)[p]2qQ12qp[p+1]q

    and, for all n=3,4,5,,

    |an+p1|(1+q)[p]2qQ12qp[n+p1]q[n1]qn2j=1(1+(1+q)[p]qQ12qp[j]q).

    Putting p=1 in Theorems 3 and 4, we obtain the following corollaries.

    Corollary 7. If fk-STq, then

    |a2|(1+q)Q12q

    and, for all n=3,4,5,,

    |an|(1+q)Q12q[n1]qn2j=1(1+(1+q)Q12q[j]q).

    Corollary 8. If fk-UCVq, then

    |a2|Q12q

    and, for all n=3,4,5,,

    |an|(1+q)Q12q[n]q[n1]qn2j=1(1+(1+q)Q12q[j]q).

    Theorem 5. Let fk-STq,p. Then f(U) contains an open disk of the radius given by

    r=2qp2(p+1)qp+(1+q)[p]qQ1.

    Proof. Let w00 be a complex number such that f(z)w0 for zU. Then

    f1(z)=w0f(z)w0f(z)=zp+1+(ap+1+1w0)zp+1+.

    Since f1 is univalent, so

    |ap+1+1w0|p+1.

    Now, using Theorem 3, we have

    |1w0|p+1+(1+q)[p]qQ12qp=2qp(p+1)+(1+q)[p]qQ12qp.

    Hence

    |w0|2qp2qp(p+1)+(1+q)[p]qQ1.

    This completes the proof of Theorem 5.

    Theorem 6. Let the function fk-STq,p be of the form (1.1). Then, for a complex number μ,

    |ap+2μa2p+1|[p]qQ12qpmax{1,|Q2Q1+([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q[p]q(1+q)qp(1q))|}. (3.8)

    The result is sharp.

    Proof. If fk-STq,p, we have

    zDqf(z)[p]qf(z)pk,q(z)=2pk(z)(1+q)+(1q)pk(z).

    From the definition of the differential subordination, we know that

    zDqf(z)[p]qf(z)=pk,q(w(z))(zU), (3.9)

    where w(z) is a Schwarz function with w(0)=0 and |w(z)|<1 for zU.

    Let hP be a function defined by

    h(z)=1+w(z)1w(z)=1+c1z+c2z2+(zU).

    This gives

    w(z)=12c1z+12(c2c212)z2+

    and

    pk,q(w(z))=1+1+q4c1Q1z+1+q4{Q1c2+12(Q2Q11q2Q21)c21}z2+. (3.10)

    Using (3.10) in (3.9), we obtain

    ap+1=(1+q)[p]qc1Q14qp

    and

    ap+2=[p]qQ14qp[c212(1Q2Q1[p]q(1+q)qp(1q)2qpQ1)c21]

    Now, for any complex number μ, we have

    ap+2μa2p+1=[p]qQ14qp[c212(1Q2Q1[p]q(1+q)qp(1q)2qpQ1)c21]μ(1+q)2[p]2qQ21c2116q2p. (3.11)

    Then (3.11) can be written as follows:

    ap+2μa2p+1=[p]qQ14qp{c2vc21}, (3.12)

    where

    v=12[1Q2Q1([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q[p]q(1+q)qp(1q))]. (3.13)

    Finally, by taking the moduli on both sides and using Lemma 4, we obtain the required result. The sharpness of (3.8) follows from the sharpness of (2.5). Our demonstration of Theorem 6 is thus completed.

    Similarly, we can prove the following theorem.

    Theorem 7. Let the function fk-UCVq,p be of the form (1.1). Then, for a complex number μ,

    |ap+2μa2p+1|[p]2qQ12qp[p+2]qmax{1,|Q2Q1+((1+q)[p]q(1q)qp)Q12qp(1μ[p+2]q(1+q)2[p]2q((1+q)[p]q(1q)qp)[p+1]2q)|}.

    The result is sharp.

    Putting p=1 in Theorems 6 and 7, we obtain the following corollaries.

    Corollary 9. Let the function fk-STq be of the form (1.1) (with p=1). Then, for a complex number μ,

    |a3μa22|Q12qmax{1,|Q2Q1+(1+q2)Q12q(1μ(1+q)21+q2)|}.

    The result is sharp.

    Corollary 10. Let the function fk-UCVq be of the form (1.1) (with p=1). Then, for a complex number μ,

    |a3μa22|Q12q[3]qmax{1,|Q2Q1+(1+q2)Q12q(1μ[3]q1+q2)|}.

    The result is sharp.

    Theorem 8. Let

    σ1=([p]q(1+q)qp(1q))Q21+2qp(Q2Q1)[p]q(1+q)2Q21,
    σ2=([p]q(1+q)qp(1q))Q21+2qp(Q2+Q1)[p]q(1+q)2Q21

    and

    σ3=([p]q(1+q)qp(1q))Q21+2qpQ2[p]q(1+q)2Q21.

    If the function f given by (1.1) belongs to the class k-STq,p, then

    |ap+2μa2p+1|{[p]qQ12qp{Q2Q1+([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q[p]q(1+q)qp(1q))}(μσ1)[p]qQ12qp(σ1μσ2),[p]qQ12qp{Q2Q1+([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q[p]q(1+q)qp(1q))}(μσ2).

    Furthermore, if σ1μσ3, then

    |ap+2μa2p+1|+2qp(1+q)2[p]qQ1{1Q2Q1([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q([p]q(1+q)qp(1q)))}|ap+1|2[p]qQ12qp.

    If σ3μσ2, then

    |ap+2μa2p+1|+2qp(1+q)2[p]qQ1{1+Q2Q1+([p]q(1+q)qp(1q))Q12qp(1μ(1+q)2[p]q([p]q(1+q)qp(1q)))}|ap+1|2[p]qQ12qp.

    Proof. Applying Lemma 4 to (3.12) and (3.13), respectively, we can derive the results asserted by Theorem 8.

    Putting p=1 in Theorem 8, we obtain the following result.

    Corollary 11. Let

    σ4=(1+q2)Q21+2q(Q2Q1)(1+q)2Q21,
    σ5=(1+q2)Q21+2q(Q2+Q1)(1+q)2Q21

    and

    σ6=(1+q2)Q21+2qQ2(1+q)2Q21.

    If the function f given by (1.1) (with p=1) belongs to the class k-STq, then

    |a3μa22|{Q12q{Q2Q1+(1+q2)Q12q(1μ(1+q)21+q2)}(μσ4)Q12q(σ4μσ5)Q12q{Q2Q1+(1+q2)Q12q(1μ(1+q)21+q2)}(μσ5).

    Furthermore, if σ4μσ6, then

    |a3μa22|+2q(1+q)2Q1{1Q2Q1(1+q2)Q12q(1μ(1+q)21+q2)}|a2|2Q12q.

    If σ3μσ2, then

    |a3μa22|+2q(1+q)2Q1{1+Q2Q1+(1+q2)Q12q(1μ(1+q)21+q2)}|a2|2Q12q.

    Similarly, we can prove the following result.

    Theorem 9. Let

    η1=[((1+q)[p]q(1q)qp)Q21+2qp(Q2Q1)][p+1]2q[p]2q[p+2]q(1+q)2Q21,
    η2=[((1+q)[p]q(1q)qp)Q21+2qp(Q2+Q1)][p+1]2q[p]2q[p+2]q(1+q)2Q21

    and

    η3=[((1+q)[p]q(1q)qp)Q21+2qpQ2][p+1]2q[p]2q[p+2]q(1+q)2Q21.

    If the function f given by (1.1) belongs to the class k-UCVq,p, then

    |ap+2μa2p+1|{[p]2qQ12qp[p+2]q{Q2Q1+((1+q)[p]q(1q)qp)Q12qp(1[p+2]q(1+q)2[p]2q μ((1+q)[p]q(1q)qp)[p+1]2q)}(μη1)[p]2qQ12qp[p+2]q(η1μη2)[p]2qQ12qp[p+2]q{Q2Q1+((1+q)[p]q(1q)qp)Q12qp(1[p+2]q(1+q)2[p]2q μ((1+q)[p]q(1q)qp)[p+1]2q)}(μη2).

    Furthermore, if η1μη3, then

    |ap+2μa2p+1|+2qp[p+1]2qQ1[p+2]q(1+q)2[p]2qQ21{1Q2Q1((1+q)[p]q(1q)qp)Q12qp(1μ[p+2]q(1+q)2[p]2q((1+q)[p]q(1q)qp)[p+1]2q)}|ap+1|2[p]2qQ12qp[p+2]q.

    If η3μη2, then

    |ap+2μa2p+1|+2qp[p+1]2qQ1[p+2]q(1+q)2[p]2qQ21{1+Q2Q1+((1+q)[p]q(1q)qp)Q12qp(1μ[p+2]q(1+q)2[p]2q((1+q)[p]q(1q)qp)[p+1]2q)}|ap+1|2[p]2qQ12qp[p+2]q.

    Putting p=1 in Theorem 9, we obtain the following result.

    Corollary 12. Let

    η4=(1+q2)Q21+2q(Q2Q1)[3]qQ21,
    η5=(1+q2)Q21+2q(Q2+Q1)[3]qQ21

    and

    η6=(1+q2)Q21+2qQ2[3]qQ21.

    If the function f given by (1.1) (with p=1) belongs to the class k-UCVq, then

    |a3μa22|{Q12q[3]q{Q2Q1+(1+q2)Q12q(1μ[3]q1+q2)}(μη4)Q12q[3]q(η4μη5)Q12q[3]q{Q2Q1+(1+q2)Q12q(1μ[3]q1+q2)}(μη5).

    Furthermore, if η4μη6, then

    |a3μa22|+2q[3]qQ1{1Q2Q1(1+q2)Q12q(1μ[3]q1+q2)}|a2|2Q12q[3]q.

    If η3μη2, then

    |a3μa22|+2q[3]qQ1{1+Q2Q1+(1+q2)Q12q(1μ[3]q1+q2)}|a2|2Q12q[3]q.

    In our present investigation, we have applied the concept of the basic (or q-) calculus and a generalized conic domain, which was introduced and studied earlier by Srivastava et al. (see, for example, [43,50]). By using this concept, we have defined two subclasses of normalized multivalent functions which map the open unit disk:

    U={z:zCand|z|<1}

    onto this generalized conic domain. We have derived a number of useful properties including (for example) the coefficient estimates and the Fekete-Szegö inequalities for each of these multivalent function classes. Our results are connected with those in several earlier works which are related to this field of Geometric Function Theory of Complex Analysis.

    Basic (or q-) series and basic (or q-) polynomials, especially the basic (or q-) hypergeometric functions and basic (or q-) hypergeometric polynomials, are applicable particularly in several diverse areas [see, for example, [48,pp. 350-351]. Moreover, as we remarked in the introductory Section 1 above, in the recently-published survey-cum-expository review article by Srivastava [42], the so-called (p,q)-calculus was exposed to be a rather trivial and inconsequential variation of the classical q-calculus, the additional parameter p being redundant or superfluous (see, for details, [42,p. 340]). This observation by Srivastava [42] will indeed apply to any attempt to produce the rather straightforward (p,q)-variations of the results which we have presented in this paper.

    In conclusion, with a view mainly to encouraging and motivating further researches on applications of the basic (or q-) analysis and the basic (or q-) calculus in Geometric Function Theory of Complex Analysis along the lines of our present investigation, we choose to cite a number of recently-published works (see, for details, [25,47,51,53,56] on the Fekete-Szegö problem; see also [20,21,22,23,24,27,28,35,36,37,40,44,46,49,52,55,57] dealing with various aspects of the usages of the q-derivative operator and some other operators in Geometric Function Theory of Complex Analysis). Indeed, as it is expected, each of these publications contains references to many earlier works which would offer further incentive and motivation for considering some of these worthwhile lines of future researches.

    The authors declare no conflicts of interest.



    Conflict of interest



    The authors declare no conflict of interest.

    [1] Abraham DJ, Varga J (2005) Scleroderma: From cell and molecular mechanisms to disease models. Trends Immunol 26: 587-595. doi: 10.1016/j.it.2005.09.004
    [2] Mason RC, Murray JF, Nadel JA, et al. (2015)  Murray & Nadel's Textbook of Respiratory Medicine E-Book Elsevier Health Sciences.
    [3] Feghali-Bostwick C, Medsger TA, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48: 1956-1963. doi: 10.1002/art.11173
    [4] Mayes MD, Lacey JV, Beebe-Dimmer J, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48: 2246-2255. doi: 10.1002/art.11073
    [5] Pietra GG, Capron F, Stewart S, et al. (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43: 25S-32S. doi: 10.1016/j.jacc.2004.02.033
    [6] Tashkin DP, Elashoff R, Clements PJ, et al. (2006) Cyclophosphamide versus placebo in scleroderma lung disease. New Engl J Med 354: 2655-2666. doi: 10.1056/NEJMoa055120
    [7] Clements PJ, Furst DE (2002)  Systemic Sclerosis Philadelphia: Lippincott Williams & Wilkins.
    [8] Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV AIDS 5: 463. doi: 10.1097/COH.0b013e32833ed177
    [9] Wagner J, Atkinson A (2015) Measuring biomarker progress. Clin Pharmacol Ther 98: 2-5. doi: 10.1002/cpt.133
    [10] Humbert M, Barst R, Robbins I, et al. (2004) Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J 24: 353-359. doi: 10.1183/09031936.04.00028404
    [11] Williams MH, Das C, Handler CE, et al. (2006) Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 92: 926-932. doi: 10.1136/hrt.2005.069484
    [12] Leask A (2008) Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal 20: 1409-1414. doi: 10.1016/j.cellsig.2008.01.006
    [13] Yamane K, Kashiwagi H, Suzuki N, et al. (1991) Elevated plasma levels of endothelin-1 in systemic sclerosis. Arthritis Rheum 34: 243-244. doi: 10.1002/art.1780340220
    [14] Vancheeswaran R, Azam A, Black C, et al. (1994) Localization of endothelin-1 and its binding sites in scleroderma skin. J Rheumatol 21: 1268-1276.
    [15] Kowal-Bielecka O, Landewé R, Avouac J, et al. (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68: 620-628. doi: 10.1136/ard.2008.096677
    [16] Galie N, Rubin L, Hoeper M, et al. (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): A double-blind, randomised controlled trial. Lancet 371: 2093-2100. doi: 10.1016/S0140-6736(08)60919-8
    [17] Clements P, Lachenbruch P, Seibold J, et al. (1993) Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 20: 1892-1896.
    [18] Codullo V, Cavazzana I, Bonino C, et al. (2009) Serologic profile and mortality rates of scleroderma renal crisis in Italy. J Rheumatol 36: 1464-1469. doi: 10.3899/jrheum.080806
    [19] Szamosi S, Szekanecz Z, Szűcs G (2006) Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int 26: 1120-1124. doi: 10.1007/s00296-006-0146-z
    [20] Mayes MD (1996) Scleroderma epidemiology. Rheum Dis Clin North Am 22: 751-764. doi: 10.1016/S0889-857X(05)70299-4
    [21] Valentini G, Black C (2002) Systemic sclerosis. Best Pract Res Clin Rheumatol 16: 807-816. doi: 10.1053/berh.2002.0258
    [22] Mottaghi P, Karimifar M, Salesi M, et al. (2010) Parenchymal lung involvement in patients with systemic sclerosis admitted to Isfahan's Noor and Al-Zahra Hospitals. Razi J Med Sci 17: 67-72.
    [23] Wells A, Hansell D, Rubens M, et al. (1997) Fibrosing alveolitis in systemic sclerosis. Indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum 40: 1229-1236.
    [24] Steen VD, Owens GR, Fino GJ, et al. (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 28: 759-767. doi: 10.1002/art.1780280706
    [25] Guillen-Del Castillo A, Simeón-Aznar CP, Fonollosa-Pla V, et al. (2014) Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody. Semin Arthritis Rheum 44: 331-337. doi: 10.1016/j.semarthrit.2014.07.002
    [26] Peters-Golden M, Wise RA, Schneider P, et al. (1984) Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine 63: 221-231. doi: 10.1097/00005792-198407000-00004
    [27] Whalley D, Mckenna SP, De Jong Z, et al. (1997) Quality of life in rheumatoid arthritis. Br J Rheumatol 36: 884-888. doi: 10.1093/rheumatology/36.8.884
    [28] Aghaei M, Gharibdost F, Zayeni H, et al. (2011) The Correlation between endothelin-1 antibody plasma concentrations in patients with scleroderma and different manifestations of the disease. Tehran Univ Med J 68.
    [29] Walker U, Tyndall A, Czirjak L, et al. (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 66: 754-763. doi: 10.1136/ard.2006.062901
    [30] Yamane K, Miyauchi T, Suzuki N, et al. (1992) Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol 19: 1566-1571.
    [31] Vancheeswaran R, Magoulas T, Efrat G, et al. (1994) Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? J Rheumatol 21: 1838-1844.
    [32] Horowitz JC, Ajayi IO, Kulasekaran P, et al. (2012) Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis. Int J Biochem Cell Biol 44: 158-169. doi: 10.1016/j.biocel.2011.10.011
    [33] Cozzani E, Javor S, Laborai E, et al. (2013) Endothelin-1 levels in scleroderma patients: A pilot study. ISRN Dermatol 2013: 125632. doi: 10.1155/2013/125632
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3468) PDF downloads(113) Cited by(1)

Figures and Tables

Figures(1)  /  Tables(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog